Skip to main content
Premium Trial:

Request an Annual Quote

Europe's IMI Plans $230M Life Sciences Spending

NEW YORK (GenomeWeb News) – The Innovative Medicines Initiative, a European public-private funding partnership between the European Commission and the European pharmaceutical industry, plans to spend €156.3 million ($228 million) to support a range of life sciences research.

IMI has listed its priority research areas for funding its second call, including studies that will seek to develop new molecular biomarkers for accelerating cancer therapy development, rapid point-of-care diagnostic tests for bacterial diagnosis, imaging biomarkers for cancer drug development, and new target validation tools for oncology.

The funding includes €768 million from the European Commission and €79.5 million from European pharmaceutical companies.

Filed under

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.